Switching From Ozempic to Compounded Semaglutide
If you’re already injecting a GLP-1 and paying brand prices, this is the guide to moving to the same active ingredient at $59-$299/month - what actually happens, what the clinician decides, and what to verify before you move.
Last updated: Aug 16, 2026
We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
The short answer
Ozempic and Wegovy are semaglutide; Zepbound and Mounjaro are tirzepatide. Licensed telehealth providers prescribe compounded versions of the same molecules for $59-$299/month- versus $1,149-$1,599/month at brand list prices. Switching means completing the new provider’s medical intake, disclosing your current medication and dose, and letting its licensed clinician set your continuation dose. Start before your current supply runs out: approval-to-delivery takes between a day and a week depending on the provider.
The price gap, in real numbers
Brand list prices below are taken from our providers’ own brand-name shelves - not estimates. The compounded equivalents are in the index further down.
| Brand drug | Active ingredient | Brand list price | Compounded from |
|---|---|---|---|
| Ozempic | Semaglutide | $1,149-$1,399/mo altRx $1,149 · wellmedr $1,399 | $59/mo |
| Zepbound | Tirzepatide | $1,249-$1,599/mo altRx $1,249 · wellmedr $1,599 | $99/mo |
| Wegovy | Semaglutide | $1,579/mo altRx | $59/mo |
At the widest gap - Wegovy $1,579 vs wellmedr’s $59 semaglutide plan - the difference is over $18,000 a year. Compounded products are not FDA-approved brand drugs; the quality bar lives with the pharmacy, which is what the checklist below is for.
How the switch actually works
Pick the provider before you run out
Approval and first shipment take from a day to about a week depending on the provider (embody reviews chart-review in ~24 hours and ships in 1-2 days; altRx ships in 5-7 days). Start the switch while you still have one or two doses left so there's no gap in treatment.
Complete the intake - and disclose your current medication and dose
Every legitimate provider starts with a medical questionnaire. Report that you're currently on Ozempic, Wegovy or Zepbound and your exact current dose. This is the single most important step: it's what lets the reviewing clinician plan a continuation rather than treating you as a new starter.
A licensed clinician decides your starting dose
The new provider's clinician - not you, and not a sales page - decides whether to continue near your current dose or adjust. Don't assume a 1:1 continuation is automatic; it's a clinical decision based on your history, and reputable providers (HealthRx states it explicitly) never make approval automatic.
Your medication ships from a licensed pharmacy
Compounded semaglutide and tirzepatide ship as vials with syringes (some providers also offer needle-free formats - DirectMeds' sublingual drops, Medvi's dissolving tablets). Cold-chain shipping matters for injectables: embody and HealthRx ship temperature-controlled.
Keep the same weekly rhythm, watch how you respond
Dosing stays weekly for injectables, and side-effect expectations are the same molecule-for-molecule. If anything feels different as you transition, use the provider's check-ins - that follow-up layer is included in every program we rank.
Know your dose before the intake: the standard titration ladders
The intake will ask what you take and at what dose - answer from your pen or your pharmacy label, not from memory. For reference, these are the FDA-label titration schedules for the brand drugs people switch from:
| Brand drug | Starting dose | Escalation steps | Full / maintenance dose |
|---|---|---|---|
| Wegovy (semaglutide) | 0.25 mg weekly, weeks 1-4 | 0.5 mg → 1 mg → 1.7 mg, stepping up every 4 weeks | 2.4 mg weekly |
| Ozempic (semaglutide) | 0.25 mg weekly, first 4 weeks | 0.5 mg, then 1 mg if needed | up to 2 mg weekly |
| Zepbound / Mounjaro (tirzepatide) | 2.5 mg weekly, weeks 1-4 | increase in 2.5 mg steps, at least 4 weeks apart | 5, 10 or 15 mg weekly |
Schedules from the drugs’ FDA prescribing information; your prescriber may have deviated from them. Compounded programs dose in the same molecule but their clinician sets your continuation dose individually - being mid-ladder on the brand doesn’t guarantee the same rung on the new program. Several providers charge the same price at every dose (wellmedr, altRx, DirectMeds, embody), so a higher continuation dose doesn’t have to cost more.
Side effects don’t change with the switch: the trial numbers
Compounded semaglutide and tirzepatide are the same active molecules, so the published side-effect profile is your best guide to what to expect - mostly digestive, mostly during dose increases, mostly easing as your body adjusts:
| Reported event | Semaglutide 2.4 mg (STEP 1, 68 wks) | Tirzepatide 5-15 mg (SURMOUNT-1, 72 wks) |
|---|---|---|
| Nausea | ~44% | ~25-33% across doses |
| Diarrhea | ~32% | ~19-23% across doses |
| Vomiting | ~25% | ~8-13% across doses |
| Constipation | ~23% | ~12-17% across doses |
Approximate rates over the full trial periods, from the published STEP 1 and SURMOUNT-1 studies cited in the sources below; events were predominantly mild-to-moderate and concentrated around dose escalation. If you switch at your established dose rather than restarting the ladder, you may skip the roughest titration weeks - another reason the intake disclosure matters. Seek care promptly for severe or persistent symptoms.
The pre-switch verification checklist
| Check | Why it matters | Who clears it today |
|---|---|---|
| Clinician review, never automatic approval | A licensed clinician who can decline or adjust is the safety layer. A site promising guaranteed approval is a red flag. | All 8 ranked providers; HealthRx states it explicitly |
| Licensed 503A compounding pharmacies | The compound is only as good as the pharmacy preparing it - state licensure is the quality floor. | embody and HealthRx name 503A fulfillment |
| LegitScript certification | Independent, revocable certification of the telehealth operation itself. | embody; HealthRx (cert. 50087439) |
| Cold-chain, tracked shipping | Semaglutide and tirzepatide are temperature-sensitive; injectables should arrive cold, with ice packs, fast. | embody (1-2 days); HealthRx (overnight) |
| Price at YOUR dose, not the headline | Switchers often arrive mid-titration; per-dose pricing can beat the advertised rate out of you. | Flat at every dose: wellmedr, altRx, DirectMeds, embody |
Where switchers land: the price index
The same verified index from our cheapest GLP-1 ranking - real published prices, cheapest first, conditions disclosed.
Lowest ongoing price on the market - same price at every dose
Ships in 3-5 business days · Trustpilot 4.7 across 1,205 reviews
Semaglutide
12-month plan; locked for life
Tirzepatide
shipped every 4 weeks
Cheapest with no commitment - month to month, ships in 1-2 days
Ships in 1-2 days, cold-chain · Trustpilot 3.8 across 4,956 reviews
Semaglutide
reg. $79; month-to-month
Tirzepatide
reg. $129; month-to-month
Flat pricing at every dose, plus a real brand-name shelf
Free shipping in 5-7 days · No published Trustpilot rating
Semaglutide
reg. $199; flat at every dose
Tirzepatide
reg. $299; flat at every dose
All-in prepaid year with overnight cold-chain delivery
Overnight cold-chain shipping · No published Trustpilot rating
Semaglutide
12-mo prepaid - $1,188 at checkout
Tirzepatide
per month
One flat price for both medications - injections or drops
Free 1-2 day shipping · Trustpilot 4.6 across 13,901 reviews
Semaglutide
flat at every dose
Tirzepatide
flat at every dose
All-inclusive care: visits, dietician and coaching in the price
Free shipping · Trustpilot 4.4 across 14,372 reviews
Semaglutide
all-inclusive; tablets $249
Tirzepatide
not offered
Custom dosing with unlimited provider check-ins
Free tracked delivery, often next-day · Trustpilot 3.6 across 5,497 reviews
Semaglutide
first month; reg. $299
Tirzepatide
per month
Coaching included and a 5%-in-120-days money-back guarantee
Home delivery included · Trustpilot 4.7 across 1,120 reviews
Semaglutide
20% off month one
Tirzepatide
20% off month one
Switching From Ozempic: FAQs
Can I switch from Ozempic to compounded semaglutide?
Yes - this is one of the most common paths onto telehealth GLP-1 programs. Ozempic's active ingredient is semaglutide, and compounded semaglutide is the same molecule prepared by a state-licensed compounding pharmacy. You complete the new provider's medical intake, disclose your current medication and dose, and a licensed clinician decides your starting dose on the new program. Compounded products are not FDA-approved brand drugs, so provider and pharmacy quality matter - see what to verify below.
How much cheaper is compounded semaglutide than Ozempic?
Substantially. On our providers' own brand shelves, Ozempic lists at $1,149-$1,399/month and Wegovy at $1,579/month, while compounded semaglutide runs $59-$199/month depending on the provider and plan. Even at the most expensive compounded tier, the difference is roughly $950/month - over $11,000 a year.
Will I keep my current dose when I switch?
That's the reviewing clinician's call, and it's made from your intake - which is why disclosing your exact current medication and dose matters. Many providers charge the same price at every dose (wellmedr, altRx, DirectMeds, embody), so a higher continuation dose doesn't cost more at those programs. Never adjust your own dose during a switch without clinical guidance.
What about switching from Zepbound or Mounjaro?
Same logic, different molecule: Zepbound and Mounjaro are tirzepatide, and compounded tirzepatide is available from $99/month (wellmedr) to $299/month (SHED), versus $1,249-$1,599/month for brand Zepbound. Disclose your current dose in the intake exactly as you would with semaglutide.
Is switching to compounded safe?
The molecule is the same, but compounded products are not FDA-approved brand drugs and quality depends on the pharmacy. Reduce that risk the same way we rank providers: require a real clinician review (never automatic approval), state-licensed 503A pharmacies, LegitScript certification where available (embody, HealthRx), and cold-chain shipping for injectables. And talk to your current prescriber - continuity of care beats a silent switch.
Do I need to tell my current doctor?
You should. The telehealth provider's clinician takes over prescribing, but your own doctor knowing your full medication picture is basic safety - especially if you have other conditions or prescriptions. There's no penalty for switching; brand prescriptions simply lapse when you stop filling them.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Ozempic, Wegovy, Mounjaro, Zepbound and Rybelsus are trademarks of their respective manufacturers and are not affiliated with treatmentshub.com. Compounded medications are not FDA-approved brand drugs. This page is for information only and is not medical advice - always consult a licensed clinician about switching or starting any medication.